Observational studyFrontiers in immunology2026

Outcomes of belatacept-based quadruple immunosuppression therapy in kidney transplant recipients with persistent alloimmune response: a single-center observational study.

Basheer Ahamad Kummangal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.